D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management

Completed · Not applicable

Conditions studied: Heart Diseases

In brief

This is an acute, prospective, multi-center, non-randomized, investigational device exemption (IDE) clinical study.

Key facts

Study ID

NCT00328705

Run by

Medtronic Cardiac Rhythm and Heart Failure

People needed

65

Starts

2006-05-01

Expected to finish

2007-01-01

Last updated by the study team

2008-02-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are scheduled for implantation or replacement of an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device
• Patients must have or receive Medtronic transvenous atrial and ventricular leads in association with the scheduled device implant or replacement.

You may not qualify if…

• Patients who have 3rd degree heart block, as assessed by the investigator
• Patients who have a mechanical tricuspid heart valve
• Patients who have received an investigational new drug or device, or are currently enrolled in a clinical study for a new indication of an approved drug or device

Where it is running

• Study site — Tampa, Florida, United States
• Study site — Coon Rapids, Minnesota, United States
• Study site — Rochester, Minnesota, United States
• Study site — Saint Paul, Minnesota, United States
• Study site — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.